Literature DB >> 15858122

Processing of radical prostatectomy specimens for correlation of data from histopathological, molecular biological, and radiological studies: a new whole organ technique.

S G Jhavar1, C Fisher, A Jackson, S A Reinsberg, N Dennis, A Falconer, D Dearnaley, S E Edwards, S M Edwards, M O Leach, C Cummings, T Christmas, A Thompson, C Woodhouse, S Sandhu, C S Cooper, R A Eeles.   

Abstract

AIMS: To develop a method of processing non-formalin fixed prostate specimens removed at radical prostatectomy to obtain fresh tissue for research and for correlating diagnostic and molecular results with preoperative imaging. METHODS/
RESULTS: The method involves a prostate slicing apparatus comprising a tissue slicer with a series of juxtaposed planar stainless steel blades linked to a support, and a cradle adapted to grip the tissue sample and receive the blades. The fresh prostate gland is held in the cradle and the blades are moved through the cradle slits to produce multiple 4 mm slices of the gland in a plane perpendicular to its posterior surface. One of the resulting slices is preserved in RNAlater. The areas comprising tumour and normal glands within this preserved slice can be identified by matching it to the haematoxylin and eosin stained sections of the adjacent slices that are formalin fixed and paraffin wax embedded. Intact RNA can be extracted from the identified tumour and normal glands within the RNAlater preserved slice. Preoperative imaging studies are acquired with the angulation of axial images chosen to be similar to the slicing axis, such that stained sections from the formalin fixed, paraffin wax embedded slices match their counterparts on imaging.
CONCLUSIONS: A novel method of sampling fresh prostate removed at radical prostatectomy that allows tissue samples to be used both for diagnosis and molecular analysis is described. This method also allows the integration of preoperative imaging data with histopathological and molecular data obtained from the prostate tissue slices.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15858122      PMCID: PMC1770644          DOI: 10.1136/jcp.2004.021808

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  20 in total

Review 1.  Effect of formalin tissue fixation and processing on immunohistochemistry.

Authors:  M Werner; A Chott; A Fabiano; H Battifora
Journal:  Am J Surg Pathol       Date:  2000-07       Impact factor: 6.394

2.  Frozen tumor tissue microarray technology for analysis of tumor RNA, DNA, and proteins.

Authors:  M Schoenberg Fejzo; D J Slamon
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

3.  Proliferative heterogeneity in the human prostate: evidence for epithelial stem cells.

Authors:  D L Hudson; M O'Hare; F M Watt; J R Masters
Journal:  Lab Invest       Date:  2000-08       Impact factor: 5.662

4.  Whole mounted radical prostatectomy specimens do not increase detection of adverse pathological features.

Authors:  B K Hollenbeck; N Bassily; J T Wei; J E Montie; S Hayasaka; J M Taylor; M A Rubin
Journal:  J Urol       Date:  2000-11       Impact factor: 7.450

5.  Preservation of RNA for functional genomic studies: a multidisciplinary tumor bank protocol.

Authors:  S R Florell; C M Coffin; J A Holden; J W Zimmermann; J W Gerwels; B K Summers; D A Jones; S A Leachman
Journal:  Mod Pathol       Date:  2001-02       Impact factor: 7.842

6.  Comparative expressed sequence hybridization to chromosomes for tumor classification and identification of genomic regions of differential gene expression.

Authors:  Y J Lu; D Williamson; J Clark; R Wang; N Tiffin; L Skelton; T Gordon; R Williams; B Allan; A Jackman; C Cooper; K Pritchard-Jones; J Shipley
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

7.  Potential improvements in the therapeutic ratio of prostate cancer irradiation: dose escalation of pathologically identified tumour nodules using intensity modulated radiotherapy.

Authors:  C M Nutting; C M Corbishley; B Sanchez-Nieto; V P Cosgrove; S Webb; D P Dearnaley
Journal:  Br J Radiol       Date:  2002-02       Impact factor: 3.039

8.  Methods of radical prostatectomy specimen processing: a novel technique for harvesting fresh prostate cancer tissue and review of processing techniques.

Authors:  G S Bova; W M Fox; J I Epstein
Journal:  Mod Pathol       Date:  1993-03       Impact factor: 7.842

9.  Heterogeneity of prostate cancer in radical prostatectomy specimens.

Authors:  M Aihara; T M Wheeler; M Ohori; P T Scardino
Journal:  Urology       Date:  1994-01       Impact factor: 2.649

Review 10.  Applications of microarray technology in breast cancer research.

Authors:  C S Cooper
Journal:  Breast Cancer Res       Date:  2001-03-20       Impact factor: 6.466

View more
  16 in total

1.  A method for correlating in vivo prostate magnetic resonance imaging and histopathology using individualized magnetic resonance-based molds.

Authors:  Vijay Shah; Thomas Pohida; Baris Turkbey; Haresh Mani; Maria Merino; Peter A Pinto; Peter Choyke; Marcelino Bernardo
Journal:  Rev Sci Instrum       Date:  2009-10       Impact factor: 1.523

Review 2.  Optimum slicing of radical prostatectomy specimens for correlation between histopathology and medical images.

Authors:  Li Hong Chen; Henry Ho; Richie Lazaro; Choon Hua Thng; John Yuen; Wan Sing Ng; Chris Cheng
Journal:  Int J Comput Assist Radiol Surg       Date:  2010-02-24       Impact factor: 2.924

3.  Use of patient-specific MRI-based prostate mold for validation of multiparametric MRI in localization of prostate cancer.

Authors:  Hari Trivedi; Baris Turkbey; Ardeshir R Rastinehad; Compton J Benjamin; Marcelino Bernardo; Thomas Pohida; Vijay Shah; Maria J Merino; Bradford J Wood; W Marston Linehan; Aradhana M Venkatesan; Peter L Choyke; Peter A Pinto
Journal:  Urology       Date:  2012-01       Impact factor: 2.649

4.  Next-generation prostate cancer biobanking: toward a processing protocol amenable for the International Cancer Genome Consortium.

Authors:  Raquel Esgueva; Kyung Park; Robert Kim; Naoki Kitabayashi; Christopher E Barbieri; Philip J Dorsey; Cyril Abraham; Samprit Banerjee; Robert A Leung; Ashutosh K Tewari; Stéphane Terry; Maria M Shevchuk; David S Rickman; Mark A Rubin
Journal:  Diagn Mol Pathol       Date:  2012-06

Review 5.  A decade in prostate cancer: from NMR to metabolomics.

Authors:  Elita M DeFeo; Chin-Lee Wu; W Scott McDougal; Leo L Cheng
Journal:  Nat Rev Urol       Date:  2011-05-17       Impact factor: 14.432

6.  Ceramic foam plates: a new tool for processing fresh radical prostatectomy specimens.

Authors:  Tatjana Vlajnic; Martin Oeggerli; Cyrill Rentsch; Heike Püschel; Tobias Zellweger; George N Thalmann; Christian Ruiz; Lukas Bubendorf
Journal:  Virchows Arch       Date:  2014-10-17       Impact factor: 4.064

Review 7.  Molecular markers in prostate cancer. Part I: predicting lethality.

Authors:  Sachin Agrawal; William D Dunsmuir
Journal:  Asian J Androl       Date:  2008-12-01       Impact factor: 3.285

8.  Decision support system for localizing prostate cancer based on multiparametric magnetic resonance imaging.

Authors:  Vijay Shah; Baris Turkbey; Haresh Mani; Yuxi Pang; Thomas Pohida; Maria J Merino; Peter A Pinto; Peter L Choyke; Marcelino Bernardo
Journal:  Med Phys       Date:  2012-07       Impact factor: 4.071

9.  Customized Tool for the Validation of Optical Coherence Tomography in Differentiation of Prostate Cancer.

Authors:  B G Muller; A Swaan; D M de Bruin; W van den Bos; A W Schreurs; D J Faber; E C H Zwartkruis; L Rozendaal; A N Vis; J A Nieuwenhuijzen; R J A van Moorselaar; T G van Leeuwen; J J M C H de la Rosette
Journal:  Technol Cancer Res Treat       Date:  2016-07-07

10.  Detection of TMPRSS2-ERG translocations in human prostate cancer by expression profiling using GeneChip Human Exon 1.0 ST arrays.

Authors:  Sameer Jhavar; Alison Reid; Jeremy Clark; Zsofia Kote-Jarai; Timothy Christmas; Alan Thompson; Christopher Woodhouse; Christopher Ogden; Cyril Fisher; Cathy Corbishley; Johann De-Bono; Rosalind Eeles; Daniel Brewer; Colin Cooper
Journal:  J Mol Diagn       Date:  2007-12-28       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.